Mr. Max Schwartz reports

ORGANIGRAM ANNOUNCES APPOINTMENT OF KARINA GEHRING TO BOARD OF DIRECTORS

Organigram Holdings Inc. has appointed Karina Gehring to the Organigram board of directors at the company's annual general and special meeting held on Jan. 18, 2024.

"We are thrilled to welcome Karina to our board of directors. Her extensive expertise in marketing and brand management, combined with her ongoing experience with BAT will be a tremendous asset to our board," said Peter Amirault, board chair, Organigram.

Mrs. Gehring is one of two directors (including Simon Ashton) designated by BT DE Investments Inc., a wholly owned subsidiary of British American Tobacco PLC (BAT), as nominees to the company's board. Bringing over 25 years of experience in marketing and trade at BAT, Mrs. Gehring is a seasoned executive proficient in commercial delivery, brand management, strategy, consumer insights and key account management. Leading diverse teams, she has played a pivotal role in transformative initiatives across Europe and Canada. Mrs. Gehring has successfully executed full portfolio brand repositioning, deepened BAT's consumer understanding to foster connections beyond surface insights and introduced innovative key account management programs.

About Organigram Holdings Inc.

Organigram Holdings is a NASDAQ Global Select Market- and Toronto Stock Exchange-listed company whose wholly owned subsidiaries include Organigram Inc., a licensed producer of cannabis, cannabis-derived products and cannabis infused edibles in Canada.

We seek Safe Harbor.